SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,517,955 | +116999.7% | 103,267 | +25.6% | 0.06% | -21.7% |
Q4 2022 | $10,690 | -99.8% | 82,228 | +83.8% | 0.08% | +97.6% |
Q3 2022 | $4,947,000 | +72.1% | 44,726 | +52.8% | 0.04% | +133.3% |
Q4 2020 | $2,875,000 | +5.2% | 29,270 | +47.5% | 0.02% | -10.0% |
Q3 2020 | $2,734,000 | -17.4% | 19,848 | -1.3% | 0.02% | -20.0% |
Q2 2020 | $3,309,000 | +14.7% | 20,113 | -15.2% | 0.02% | -3.8% |
Q1 2020 | $2,884,000 | -0.6% | 23,731 | -3.6% | 0.03% | +18.2% |
Q4 2019 | $2,901,000 | +33.7% | 24,621 | -5.2% | 0.02% | +29.4% |
Q3 2019 | $2,169,000 | -41.1% | 25,971 | +8.5% | 0.02% | -43.3% |
Q2 2019 | $3,685,000 | +19.5% | 23,927 | -1.8% | 0.03% | +20.0% |
Q1 2019 | $3,084,000 | +6.8% | 24,358 | -2.3% | 0.02% | 0.0% |
Q4 2018 | $2,887,000 | +8.8% | 24,933 | +26.2% | 0.02% | +19.0% |
Q3 2018 | $2,654,000 | +18.1% | 19,760 | +20.7% | 0.02% | +31.2% |
Q2 2018 | $2,248,000 | +76.6% | 16,374 | +1.1% | 0.02% | +77.8% |
Q1 2018 | $1,273,000 | +14.7% | 16,202 | -4.0% | 0.01% | +28.6% |
Q4 2017 | $1,110,000 | – | 16,875 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |